Hofseth Biocare ASA (HOFBF) has released an update.
Hofseth BioCare announces a study published in the International Journal of Molecular Sciences showcasing the positive impact of its salmon oil, OmeGo®, on COVID-19 recovery. The research highlights OmeGo®’s ability to lower inflammation and support immune responses, indicating potential benefits for long COVID management and other immune health applications. The company underscores sustainably sourced salmon off-cuts as a valuable resource for developing nutritional products with broad health benefits.
For further insights into HOFBF stock, check out TipRanks’ Stock Analysis page.
